cardiovascular health

Driving down heart disease costs: Tips for plans, providers
Driving down heart disease costs: Tips for plans, providersHeart disease takes a heavy toll on the healthcare system, but promising new treatments are emerging
Physicians' role in work-based health programsIn a presentation, Nancy Brown, CEO of American Heart Association, highlighted key findings of the AHA’s CEO Roundtable conducted to learn more about the state of workplace health and employee perceptions in the United States.
Remote monitoring by pharmacists can boost patient outcomesPharmacists who provide remote monitoring of three chronic disease states can help patients improve health targets
FDA expands Brilinta approval for long-term use in patients with heart attack historyFDA has expanded approval for ticagrelor (Brilinta, AstraZeneca) to include long-term use in patients with a history of heart attack.
Diabetes drug may reduce stroke, CV deathsJardiance is the first diabetes drug that has also been shown to lower strokes, heart attacks and cardiovascular deaths, according to a new study.
Ramifications of pelvic exam guidelinesHave pelvic guideline changes led to a reduction in other recommended screenings? Plus, how does menopause impact future cardiovascular health? And: Does childhood stress lead to negative obstetric outcomes?
FDA approves new heart failure drugThe FDA this week approved Novartis’s sacubitril/valsartan (Entresto) tablets to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction (HFrEF).
Obstetric history and CVD risk
Obstetric history and CVD riskHow a woman’s body responds to pregnancy may predict her later cardiovascular health.
New study to evaluate lipid management in clinical practiceAs lipid management in the United States under goes transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.
Statins cost-effective in elderly patients: StudyStatins could be a cost-effective tool for preventing heart attacks and other cardiovascular incidents in adults over aged 75 years, but the benefits would need to be weighed against potential side effects, a study in the Annals of Internal Medicine.